CRPC — Critical Reagent Processing Balance Sheet
0.000.00%
- CA$0.49m
- -CA$1.23m
Annual balance sheet for Critical Reagent Processing, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.142 | 1.81 | 3.73 | 2.67 | 1.99 |
Net Total Receivables | 0.011 | 0.04 | 0.084 | 0.013 | 0.024 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.163 | 1.88 | 3.81 | 2.69 | 2.04 |
Net Property, Plant And Equipment | — | 2.12 | 2.12 | 0.163 | 0.397 |
Total Assets | 0.163 | 4 | 5.94 | 2.86 | 2.43 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.133 | 0.212 | 0.265 | 0.145 | 0.147 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.133 | 0.212 | 0.265 | 0.145 | 0.147 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.031 | 3.79 | 5.67 | 2.71 | 2.29 |
Total Liabilities & Shareholders' Equity | 0.163 | 4 | 5.94 | 2.86 | 2.43 |
Total Common Shares Outstanding |